Telluride has a way of producing surprise titles, but the unannounced film Variety described this week may be one of the more unusual. The magazine says Nathan Fielder has co-directed a 174-minute documentary about Elizabeth Holmes, the former Theranos chief executive who is serving an 11-year prison sentence after being convicted of defrauding investors.
According to Variety’s review, the film is called You Can See Everything and was screened as a mystery title at the festival. The piece describes it as a hybrid work that sits somewhere between documentary, performance and reality-TV-style psychodrama. That description alone is enough to explain why the project has attracted attention: it takes one of Silicon Valley’s most notorious fraud cases and filters it through a creator known for blurring reality and fiction.
The reported premise is straightforward enough. Fielder and co-director Lance Oppenheim spent time with Holmes before her prison sentence began, interviewing and observing her at home in Del Mar, California. Variety says Holmes wanted someone to document her final days of freedom and that the filmmakers arrived with no clear sense of what they were really making. The result, at least in the review, is a work that is less interested in re-litigating the verdict than in asking what makes Holmes believe the version of reality she has built around herself.
The review’s account of Holmes is striking. It says the film presents her as soft-spoken and disarming while also revealing a rigid refusal to accept the meaning of her conviction. Variety notes that Fielder pushes on the contradiction between Holmes’s public image and the criminal case that ended in her imprisonment. The review also highlights a recurring theme in Holmes’s responses: a tendency to treat the failed Theranos technology as if its limitations were merely technical glitches waiting to be solved.
That tension has always been central to the Theranos story. Holmes rose to prominence after convincing investors and prominent public figures that her company had developed a revolutionary blood-testing device. The claim turned out to be false, and the collapse of Theranos became one of the defining fraud scandals of the last decade. Variety’s review says the film revisits that history while focusing less on external evidence than on Holmes’s own internal logic.
Fielder’s involvement adds another layer. Variety says the project is very much in the vein of his work on The Rehearsal and The Curse, where awkward social behavior, control and self-delusion become material for investigation. In this case, the object of study is not a fictionalized stand-in but Holmes herself, a figure whose public downfall has already been turned into documentaries, podcasts, books and courtroom commentary.
The review suggests the film is not an ordinary documentary in any sense. That may be the point. Holmes has already been exhaustively covered as a symbol of fraud, ambition and Silicon Valley excess. A more conventional treatment would add little. A strange one, by contrast, might expose something that standard true-crime framing misses: the mechanics of self-persuasion.
What the Variety piece makes clear is that the Holmes story still has commercial and cultural force years after the trial. The film’s existence shows that the Theranos scandal continues to function as a kind of Rorschach test for audiences interested in startup mythmaking, media, power and deception.
It also shows that Holmes remains a compelling subject not because she is mysterious in a grand sense, but because the gap between her claims and reality remains so difficult to ignore. If Fielder’s film manages to make that gap feel newly legible, it may find an audience far beyond the festival crowd.
For now, though, the most notable fact is the simplest one: the Theranos case is still generating new interpretations, and one of them is a three-hour Nathan Fielder film that sounds almost as improbable as the company Holmes once sold to the world.
